A P P L I C A T I O N  


1) Email your campus DDC site lead to request the industrial sponsor’s list of areas of interest.


2) Prepare your application, which must include the following items:


A) Project title

B) Names, titles, institutions, telephone numbers and email addresses of PIs and Co-PIs

C) Proposal narrative (two-page maximum). The narrative should be organized using the headings below. Each area must be addressed.

i) Significance. Describe the scope and nature of the problem you are trying to solve. Clearly state the unmet need being addressed by the technology and provide evidence to support the need from multiple stakeholder perspectives (e.g., scientist, patient, clinician and payer).

ii) Innovation and Impact. Describe the innovation of your proposed solution and the impact it could have.

iii) Aims and Work Plan. Describe the proposed project andits aims, target completion date(s) and deliverables.

iv) Budget. Describe approximate budget for the project. Budget restrictions are listed at the More Information page. Define the funding requirements for the proposed project beyond this seed award and the plan for further funding.


3) Report IP status. List any relevant background IP, including regular and provisional patent applications, and describe its ownership and whether the technology is available for licensing


4) Optional: download and complete the Target Product Profile form for your project (see below).


5) Submit your application below; file name format should be Campus_LastName.pdf


Submission deadline was June 1.  No longer accepting applications.


Contact your Site Leader if you have any questions.

A D D I T I O N A L  F O R M S

Contact your site lead to receive an optional Target Product Profile (TPP) Form

R E V I E W  C R I T E R I A

B U D G E T  J U S T I F I C A T I O N

P R E V I O U S  S U B M I S S I O N  D E A D L I N E

RFA release: May 1, 2020
Application due: 5 p.m. PST, June 1, 2020
Earliest start date: October 1, 2020


Additional Information: Successful applicant co-PIs must provide their field of specialization, IBC, IRB, and/or IACUC protocol numbers, if applicable, before funds are released. A final report must be provided to UC DDC within six months following termination of the grant.



University of California Drug Discovery Consortium Site Leads may be contacted here


© 2020 by University of California Drug Discovery Consortium